MONOPHARMA
Invest Now
Start SIP in
MONOPHARMA
Performance
- Low
- ₹25
- High
- ₹25
- 52 Week Low
- ₹22
- 52 Week High
- ₹44
- Open Price₹25
- Previous Close₹25
- Volume2,000
Investment Returns
- Over 1 Month + 0.62%
- Over 3 Month + 8.41%
- Over 6 Month -26.32%
- Over 1 Year -45.07%
Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!
Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17.6
- PEG Ratio
- -
- Market Cap Cr
- 43
- P/B Ratio
- 1.4
- Average True Range
- 0.87
- EPS
- 1.38
- Dividend Yield
- 0
- MACD Signal
- -0.32
- RSI
- 49.41
- MFI
- 32.38
Mono Pharmacare Financials
Mono Pharmacare Technicals
EMA & SMA
Current Price
₹24.50
0
(0%)

-
- Bearish Moving Average 9
-
- Bullish Moving Average 7
- 20 Day
- ₹24.43
- 50 Day
- ₹25.66
- 100 Day
- ₹28.64
- 200 Day
- ₹33.83
Resistance and Support
24.5
- R3 24.50
- R2 24.50
- R1 24.50
- S1 24.50
- S2 24.50
- S3 24.50
Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-28 | Audited Results | |
2025-04-11 | Others | To consider other business matters (Revised) |
2025-02-10 | Others | To consider other business matters |
2025-01-11 | Others | To consider and approve appointment of Ms. Drashti Rohit Chande as an Additional Independent Director of the company. |
2024-11-14 | Quarterly Results & Others | To consider other business matters. |
Mono Pharmacare F&O
About Mono Pharmacare
- NSE Symbol
- MONOPHARMA
- BSE Symbol
- Managing Director
- Mr. Panilam Lakhatariya
- ISIN
- INE0OIP01012
Similar Stocks to Mono Pharmacare
Mono Pharmacare FAQs
Mono Pharmacare share price is ₹24 As on 21 May, 2025 | 20:46
The Market Cap of Mono Pharmacare is ₹43.3 Cr As on 21 May, 2025 | 20:46
The P/E ratio of Mono Pharmacare is 17.6 As on 21 May, 2025 | 20:46
The PB ratio of Mono Pharmacare is 1.4 As on 21 May, 2025 | 20:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.